Impaired inhibition of P2Y12 by clopidogrel is a major determinant of cardiac death in diabetes mellitus patients treated by percutaneous coronary intervention

Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents

Ιoannis Iakovou · JAMA · 2005 · 3.1K citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +12

Consensus and Future Directions on the Definition of High On-Treatment Platelet Reactivity to Adenosine Diphosphate

Laurent Bonello, Udaya S. Tantry, Rossella Marcucci et al. · Journal of the American College of Cardiology · 2010 · 1.1K citations

Medicine, Hematology, Pharmacology +12

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

Stephen D. Wiviott, Eugene Braunwald, Dominick J. Angiolillo et al. · Circulation · 2008 · 757 citations

Medicine, Cardiology, Pharmacotherapy +17

Cytochrome P450 2C19 681G>A Polymorphism and High On-Clopidogrel Platelet Reactivity Associated With Adverse 1-Year Clinical Outcome of Elective Percutaneous Coronary Intervention With Drug-Eluting or Bare-Metal Stents

Dietmar Trenk, Willibald Hochholzer, Martin F. Fromm et al. · Journal of the American College of Cardiology · 2008 · 545 citations

Medicine, Cardiology, Pharmacology +17

Platelet Function Profiles in Patients With Type 2 Diabetes and Coronary Artery Disease on Combined Aspirin and Clopidogrel Treatment

Dominick J. Angiolillo, Antonio Fernández‐Ortíz, Esther Bernardo et al. · Diabetes · 2005 · 535 citations · Full text

Medicine, Hematology, Pharmacology +17